Otsuka Applies For Approval Of Bronchodilator Meptin
This article was originally published in PharmAsia News
Executive Summary
Otsuka Pharmaceuticals has applied for the domestic approval of a dry powder formulation of the bronchodilator Meptin (procaterol), the company announced Jan. 11.